The lectin like domain of thrombomodulin is involved in the defence against pyelonephritis

Thrombosis Research

Volumn 136, Issue 6, 2015, Pages 1325-1331

  Lattenist, Lionel ^a   Teske, Gwendoline ^a   Claessen, Nike ^a   Florquin, Sandrine ^a,b   Conway, Edward M ^c   Roelofs, Joris J T H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LECTIN;

ACUTE PYELONEPHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; FEMALE; GENE MUTATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; BLADDER; C57BL MOUSE; CHEMISTRY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; KIDNEY; LEUKOCYTE; METABOLISM; MICROBIOLOGY; NEUTROPHIL; PATHOGENICITY; PYELONEPHRITIS;

ANIMALS; BACTERIAL LOAD; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; LECTINS; LEUKOCYTES; MICE; MICE, INBRED C57BL; NEUTROPHILS; PYELONEPHRITIS; THROMBOMODULIN; URINARY BLADDER;

EID: 84949309396     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.11.004     Document Type: Article

References (47)

1. B.J. Barnett, and D.S. Stephens Urinary tract infection: an overview Am. J. Med. Sci. 314 4 1997 245 249
2. N.J. Webb, and P.E. Brenchley Cytokines and cell adhesion molecules in the inflammatory response during acute pyelonephritis Nephron Exp. Nephrol. 96 1 2004 e1 e6
3. V. Kumar, A.K. Abbas, N. Fausto, and et al. Pathologic basis of disease 8th ed. 2010 Saunders Elsevier
4. S.A. Cotton, R.A. Gbadegesin, S. Williams, and et al. Role of TGF-beta1 in renal parenchymal scarring following childhood urinary tract infection Kidney Int. 61 1 2002 61 67
5. D. Benador, N. Benador, D.O. Slosman, and et al. Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis J. Pediatr. 124 1 1994 17 20
6. B. Jakobsson, S. Soderlundh, and U. Berg Diagnostic significance of 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy in urinary tract infection Arch. Dis. Child. 67 11 1992 1338 1342
7. W.G. Owen, and C.T. Esmon Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C J. Biol. Chem. 256 11 1981 5532 5535
8. C.T. Esmon, and W.G. Owen The discovery of thrombomodulin J. Thromb. Haemost. 2 2 2004 209 213
9. J.E. Sadler Thrombomodulin structure and function Thromb. Haemost. 78 1 1997 392 395
10. E.M. Conway Thrombomodulin and its role in inflammation Semin. Immunopathol. 34 1 2012 107 125
11. O. Kawanami, E. Jin, M. Ghazizadeh, and et al. Heterogeneous distribution of thrombomodulin and von Willebrand factor in endothelial cells in the human pulmonary microvessels J. Nippon Med. Sch. 67 2 2000 118 125
12. S.S. McCachren, J. Diggs, J.B. Weinberg, and et al. Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages Blood 78 12 1991 3128 3132
13. E.M. Conway, B. Nowakowski, and M. Steiner-Mosonyi Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation Blood 80 5 1992 1254 1263
14. N.G. Ordonez Thrombomodulin expression in transitional cell carcinoma Am. J. Clin. Pathol. 110 3 1998 385 390
15. C.T. Esmon, N.L. Esmon, and K.W. Harris Complex-formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor-V activation J. Biol. Chem. 257 14 1982 7944 7947
16. K. Suzuki, T. Hayashi, J. Nishioka, and et al. A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation J. Biol. Chem. 264 9 1989 4872 4876
17. K. Kokame, X. Zheng, and J.E. Sadler Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C J. Biol. Chem. 273 20 1998 12135 12139
18. D.J. Stearns, S. Kurosawa, and C.T. Esmon Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation J. Biol. Chem. 264 6 1989 3352 3356
19. M. Zushi, K. Gomi, S. Yamamoto, and et al. The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity J. Biol. Chem. 264 18 1989 10351 10353
20. F.J. Walker, and P.J. Fay Regulation of blood coagulation by the protein C system FASEB J. 6 8 1992 2561 2567
21. B. White, M. Schmidt, C. Murphy, and et al. Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line Br. J. Haematol. 110 1 2000 130 134
22. M. Yuksel, K. Okajima, M. Uchiba, and et al. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes Thromb. Haemost. 88 2 2002 267 273
23. M. Brueckmann, U. Hoffmann, L. De Rossi, and et al. Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes Cytokine 26 3 2004 106 113
24. S.T. Grey, A. Tsuchida, H. Hau, and et al. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester J. Immunol. 153 8 1994 3664 3672
25. J.H. Griffin, B.V. Zlokovic, and L.O. Mosnier Protein C anticoagulant and cytoprotective pathways Int. J. Hematol. 2012
26. Y.H. Li, C.H. Kuo, G.Y. Shi, and et al. The role of thrombomodulin lectin-like domain in inflammation J. Biomed. Sci. 19 2012 34
27. E.M. Conway, M. Van de Wouwer, S. Pollefeyt, and et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways J. Exp. Med. 196 5 2002 565 577
28. T. Ito, K. Kawahara, K. Okamoto, and et al. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes Arterioscler. Thromb. Vasc. Biol. 28 10 2008 1825 1830
29. C.S. Shi, G.Y. Shi, H.M. Hsiao, and et al. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response Blood 112 9 2008 3661 3670
30. J.J. Roelofs, G.J. Teske, P.I. Bonta, and et al. Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis Kidney Int. 75 1 2009 52 59
31. L.M. Kager, W.J. Wiersinga, J.J. Roelofs, and et al. Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram-negative sepsis (melioidosis) J. Thromb. Haemost. 9 10 2011 2020 2028
32. L.M. Kager, W.J. Wiersinga, J.J. Roelofs, and et al. Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)∗ Crit. Care Med. 40 7 2012 2168 2175
33. J.J. Roelofs, K.M. Rouschop, G.J. Teske, and et al. The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis Kidney Int. 70 11 2006 1942 1947
34. H. Weiler-Guettler, P.D. Christie, D.L. Beeler, and et al. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state J. Clin. Invest. 101 9 1998 1983 1991
35. A.W. Rijneveld, S. Weijer, S. Florquin, and et al. Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide Blood 103 5 2004 1702 1709
36. D.P. Olszyna, S. Florquin, M. Sewnath, and et al. CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection J. Infect. Dis. 184 3 2001 301 307
37. M. Haraoka, L. Hang, B. Frendeus, and et al. Neutrophil recruitment and resistance to urinary tract infection J. Infect. Dis. 180 4 1999 1220 1229
38. L.M. Kager, A.F. de Vos, J.J. Roelofs, and et al. The thrombomodulin lectin-like domain does not change host responses to tuberculosis Thromb. Haemost. 2013 111(2)
39. L.M. Kager, W.J. Wiersinga, J.J. Roelofs, and et al. A thrombomodulin mutation that impairs active protein C generation is detrimental in severe pneumonia-derived Gram-negative sepsis (melioidosis) PLoS Negl. Trop. Dis. 8 4 2014 e2819
40. C. Zoja, M. Locatelli, C. Pagani, and et al. Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice J. Immunol. 189 7 2012 3661 3668
41. M. Fumino, K. Kurimoto, N. Kinoshita, and et al. Experience in the treatment with recombinant thrombomodulin on disseminated intravascular coagulation with severe urinary tract infection Hinyokika Kiyo 58 2 2012 71 74
42. M. Schouten, J.D. de Boer, C. van 't Veer, and et al. The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumonia Eur. Respir. J. 41 4 2013 935 942
43. L.M. Kager, W.J. Wiersinga, J.J. Roelofs, and et al. Mice lacking the lectin-like domain of thrombomodulin are protected against melioidosis Crit. Care Med. 42 3 2014 e221 e230
44. T. Iba, T. Miki, N. Hashiguchi, and et al. Combination of antithrombin and recombinant thrombomodulin modulates neutrophil cell-death and decreases circulating DAMPs levels in endotoxemic rats Thromb. Res. 134 1 2014 169 173
45. T. Iba, T. Miki, N. Hashiguchi, and et al. Combination of antithrombin and recombinant thrombomodulin attenuates leukocyte-endothelial interaction and suppresses the increase of intrinsic damage-associated molecular patterns in endotoxemic rats J. Surg. Res. 187 2 2014 581 586
46. K. Nakamura, E. Hatano, A. Miyagawa-Hayashino, and et al. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1 Liver Int. 34 10 2014 1473 1487
47. W.L. Lin, C.F. Chang, C.S. Shi, and et al. Recombinant lectin-like domain of thrombomodulin suppresses vascular inflammation by reducing leukocyte recruitment via interacting with Lewis Y on endothelial cells Arterioscler. Thromb. Vasc. Biol. 33 10 2013 2366 2373